Stay updated on Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.

Latest updates to the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedNew revision v3.5.4 is now listed in the study record versions, replacing the previous v3.5.3. The change updates the revision history to reflect the latest document version.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe developer revision/version displayed on the page was updated from v3.5.2 to v3.5.3, reflecting a backend/site release rather than a change to the trial’s record history.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision v3.5.2 was added. The previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision history now includes v3.5.0 and removes v3.4.3 from the list.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision history shows the latest revision is v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check103 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and older notices such as the funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.9%

Stay in the know with updates to Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.